Further testing of a new cancer drug has shown it significantly restricts tumour growth when combined with other, widely-available, chemotherapeutic drugs.
The drug, DMXAA was discovered by a team at the Auckland Cancer Society Research Centre, and is now under development by UK-based Antisoma.
It selectively restricts blood vessels feeding solid tumours. The recent studies showed DMXAA additionally impeded tumour growth when administered with other chemotherapy drugs. Further clinical studies are planned.
Complete this month's questionnaire to qualify for extra Continuing Education credits. Click here For the answers to last month's quiz click here.
PHARMACY AWARDS
Click here for entry details for the 2003 Zuellig Pharma/Pharmacy Today Awards and to find out last year's winners. Also view and purchase photos of the 2002 Awards.
THIS ISSUE
For the leading stories in our latest issue of Pharmacy Today magazine visit our welcome page.
SUBSCRIPTIONS
To subscribe to Pharmacy Today, or to purchase The Beauty Manual or The Pharmacy Healthcare Handbook click here.
